Review of 41 patients operated on for primary hyperparathyroidism (Q33983845)

30 July 2017

Review of 41 patients operated on for primary hyperparathyroidism (English)

1 reference

30 July 2017

1 reference

Mimura Y

1

1 reference

30 July 2017

Kanauchi H

2

1 reference

30 July 2017

Ogawa T

3

1 reference

30 July 2017

Kammori M

4

1 reference

30 July 2017

Kaminishi M

5

1 reference

30 July 2017

1 June 2000

1 reference

Biomedicine and Pharmacotherapy

30 July 2017

1 reference

30 July 2017

54 Suppl 1

1 reference

30 July 2017

72s-76s

1 reference

Success Rate of Cervical Exploration for Hyperparathyroidism

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Surgical treatment of primary hyperparathyroidism: an institutional perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Inhibition of immunoglobulin production by parathyroid hormone. Implications in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Somatic mutation of the MEN1 gene in parathyroid tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Role of preoperative localization in the management of primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Analysis of savings in operative time for primary hyperparathyroidism using localization with technetium 99m sestamibi scan

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Preoperative parathyroid localization: prospective evaluation of technetium 99m sestamibi.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Malignant neoplasms and parathyroid adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Associated primary hyperparathyroidism and thyroid lesions. Surgical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Calcium as a goitrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

Calcitonin Secretion in Primary Hyperparathyroidism*

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2980016-5

7 January 2021

10.1016/S0753-3322(00)80016-5

Identifiers

DOI

1 reference

30 July 2017

1 reference